Medlab Clinical Ltd
ASX:MDC
Medlab Clinical Ltd
ASX:MDC
Price:
6.6
AUD
-4.21%
Market Closed
Market Cap:
AU$15.1m
Balance Sheet
Balance Sheet Decomposition
Medlab Clinical Ltd
Medlab Clinical Ltd
Balance Sheet Decomposition is not available for
Medlab Clinical Ltd
Medlab Clinical Ltd
Balance Sheet
Medlab Clinical Ltd
Medlab Clinical Ltd
Currency: AUD
| Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
1
|
1
|
20
|
11
|
9
|
13
|
5
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
3
|
9
|
13
|
5
|
0
|
0
|
|
| Cash Equivalents |
0
|
1
|
1
|
20
|
8
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
1
|
2
|
2
|
4
|
3
|
3
|
4
|
3
|
0
|
|
| Accounts Receivables |
1
|
1
|
2
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
2
|
3
|
2
|
4
|
3
|
0
|
|
| Inventory |
0
|
1
|
1
|
1
|
2
|
1
|
1
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
2
|
1
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
2
|
3
|
4
|
24
|
19
|
14
|
18
|
9
|
3
|
0
|
|
| PP&E Net |
1
|
0
|
0
|
0
|
1
|
3
|
2
|
1
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
1
|
3
|
2
|
1
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
3
+44%
|
5
+44%
|
24
+418%
|
20
-17%
|
18
-12%
|
21
+16%
|
11
-45%
|
3
-72%
|
0
-96%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
1
|
1
|
2
|
3
|
2
|
1
|
1
|
1
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
1
|
0
|
1
|
|
| Short-Term Debt |
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| Total Current Liabilities |
2
|
1
|
1
|
2
|
5
|
4
|
5
|
3
|
2
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
0
|
0
|
|
| Minority Interest |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
1
-55%
|
1
+13%
|
1
+78%
|
5
+256%
|
6
+24%
|
6
-14%
|
3
-40%
|
2
-43%
|
1
-48%
|
|
| Equity | |||||||||||
| Common Stock |
5
|
11
|
16
|
39
|
42
|
51
|
67
|
67
|
67
|
67
|
|
| Retained Earnings |
5
|
8
|
12
|
16
|
27
|
40
|
52
|
59
|
66
|
68
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
3
+275%
|
4
+52%
|
23
+489%
|
15
-34%
|
11
-24%
|
15
+33%
|
8
-47%
|
1
-84%
|
1
N/A
|
|
| Total Liabilities & Equity |
2
N/A
|
3
+44%
|
5
+44%
|
24
+418%
|
20
-17%
|
18
-12%
|
21
+16%
|
11
-45%
|
3
-72%
|
0
-96%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
74
|
166
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
|
Switch to:
Switch to:
See Also
Discover More
